Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label extension study of adjunctive perampanel in epilepsy
2016-004945-10Phase 3
- Sponsor
- Eisai Co., Ltd.
- Start
- Aug 2017
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of perampanel in epilepsy, sponsored by Eisai Co., Ltd. Primary endpoints: Number of participants with Adverse Events and Number of participants with Serious Adverse Events.
02
Drugs
perampanel
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2016-004945-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004945-10.